Salix Coronary Plaque vs Cleerly LABS
AI Verdict
Choose Salix Coronary Plaque if…
Choose Salix Coronary Plaque if your primary need is rapid, near real-time assessment of CCTA scans at the point of care for quick diagnosis of coronary artery disease. This tool is particularly well-suited for efficiently identifying high-risk plaque features and quantifying calcifications to inform immediate clinical decisions.
View Salix Coronary Plaque →Choose Cleerly LABS if…
Choose Cleerly LABS if you require a comprehensive, AI-powered solution for personalized heart disease management, including tracking disease progression over time and detailed risk assessment. Its robust integration capabilities with PACS, RIS, and EHR systems make it ideal for incorporating advanced CCTA analysis into existing long-term patient care workflows.
View Cleerly LABS →When choosing between Salix Coronary Plaque and Cleerly LABS, physicians should consider their primary need: rapid, point-of-care assessment or comprehensive, personalized heart disease management. Salix Coronary Plaque excels in near real-time analysis of CCTA scans, providing immediate insights into plaque and stenosis. Its focus on high-risk plaque features and integrated workflow management makes it suitable for situations demanding quick diagnostic support and automated reporting. The per-scan assessment model, with a stated CPT reimbursement rate, offers a clear financial structure for its use.
Cleerly LABS, while also providing comprehensive plaque and stenosis assessment, emphasizes personalized heart disease management and tracking disease progression. Its features extend to ischemia detection with an additional module and 3D visualization, offering a more in-depth view for long-term patient care. The key practical difference lies in their immediate utility versus broader management capabilities. Salix appears geared towards efficient diagnostic throughput, while Cleerly LABS offers a more extensive platform for ongoing patient stratification and monitoring. Physicians prioritizing rapid, high-volume CCTA interpretation for immediate diagnostic decisions may lean towards Salix Coronary Plaque. Conversely, those focused on a holistic, longitudinal approach to atherosclerosis management, including risk assessment and tracking disease progression, would find Cleerly LABS more aligned with their practice needs.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Salix Coronary Plaque | Cleerly LABS |
|---|---|---|
| Pricing | Contact for pricing | Per analysis |
| Deployment | Cloud | Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Salix Coronary Plaque | Cleerly LABS |
|---|---|---|
| Product Name | Salix Coronary Plaque | Cleerly LABS |
| Company | Artrya Limited | Cleerly |
| Core Functionality (Plaque/Stenosis Assessment) | Detection and quantification of coronary plaque (atherosclerosis), Stenosis assessment, Quantification of calcifications (calcium scoring) | Comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, Comprehensive coronary plaque assessment (volume, type), Stenosis detection and quantification |
| Additional Key Features | Identification of high-risk plaque features (e.g., low-attenuation plaque, spotty calcification, positive remodeling, napkin-ring sign), Near real-time, point-of-care assessment, Automated report generation (editable) | Ischemia detection (with Cleerly ISCHEMIA module), 3D visualization of coronary arteries, Personalized heart disease risk assessment, Tracking disease progression over time, Integration with PACS, RIS, EHR via Cleerly Proxy |
Videos
Demos, reviews, and walkthroughs featuring Salix Coronary Plaque and Cleerly LABS.
Frequently Asked Questions
More Comparisons
More matchups featuring Salix Coronary Plaque or Cleerly LABS
Backers
Who funded each tool's parent company.